← Leaderboards
Michael J Robertson
Indiana Univ-Purdue Univ At Indianapolis
$1,253,918
Attributed
$1,253,918
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $259.1K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,253,918 · 3
By mechanism
R01$1,243,757 · 1
M01$10,161 · 2
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Mary C Dinauer$7,798,092
- Mitchell Goldman$10,867,864
- Rahul M Jindal$0
- Hal E. Broxmeyer$36,408,829
- Rafat Abonour$806,526
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineAutologous TransplantationLeukocyte CountHuman SubjectPharmacokineticsInterleukin 12Recombinant ProteinsNeoplasm /Cancer ImmunotherapyHuman Therapy EvaluationHematopoietic Tissue TransplantationHematopoietic Stem CellsClinical ResearchClinical Trial Phase ICancer ImmunotherapyChemotherapyBaseAutologousCessation Of LifeHematopoietic Stem Cell TransplantationCancer VaccinesHigh Dose ChemotherapyFightingCancer TherapyExhibits
Grant awards (13)
Mechanisms of STAT4 Deficiency in the Immune System of Cancer Patients$239,561
R01 · FY2011 · CA · contact PI
Mechanisms of STAT4 Deficiency in the Immune System of Cancer Patients$247,357
R01 · FY2010 · CA · contact PI
Mechanisms of STAT4 Deficiency in the Immune System of Cancer Patients$247,357
R01 · FY2009 · CA · contact PI
Mechanisms of STAT4 Deficiency in the Immune System of Cancer Patients$250,417
R01 · FY2008 · CA · contact PI
Mechanisms of STAT4 Deficiency in the Immune System of Cancer Patients$259,065
R01 · FY2007 · CA · contact PI
RECOMBINANT HUMAN INTERLEUKIN-18 FOR TREATMENT OF A PATIENT WITH METASTATIC$10,161
M01 · FY2005 · RR
RHU IL 12 AFTER HIGH DOSE &AUTOLOGOUS HEMATOPOIETIC STEM CELLS$0
M01 · FY2002 · RR
RHU IL 12 AFTER HIGH DOSE &AUTOLOGOUS HEMATOPOIETIC STEM CELLS$0
M01 · FY2001 · RR
RHU IL 12 AFTER HIGH DOSE &AUTOLOGOUS HEMATOPOIETIC STEM CELLS$0
M01 · FY2000 · RR
RHU IL 12 AFTER HIGH DOSE &AUTOLOGOUS HEMATOPOIETIC STEM CELLS$0
M01 · FY2000 · RR
RHU IL 12 AFTER HIGH DOSE &AUTOLOGOUS HEMATOPOIETIC STEM CELLS$0
M01 · FY2000 · RR
RHU IL 12 AFTER HIGH DOSE &AUTOLOGOUS HEMATOPOIETIC STEM CELLS$0
M01 · FY2000 · RR
RHU IL 12 AFTER HIGH DOSE &AUTOLOGOUS HEMATOPOIETIC STEM CELLS$0
M01 · FY2000 · RR